Carregant...

Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition

EZH2 inhibitors have gained great interest for their use as anti-cancer therapeutics. However, most research has focused on EZH2 mutant cancers and recently adverse effects of EZH2 inactivation have come to light. To determine whether colorectal cancer cells respond to EZH2 inhibition and to explore...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Koppens, Martijn AJ, Bounova, Gergana, Cornelissen-Steijger, Paulien, de Vries, Nienke, Sansom, Owen J, Wessels, Lodewyk FA, van Lohuizen, Maarten
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342517/
https://ncbi.nlm.nih.gov/pubmed/27634879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!